Isolated MCPIP and methods of use

Details for Australian Patent Application No. 2006331649 (hide)

Owner University of Central Florida Research Foundation

Inventors Niu, Jianli; Kolattukudy, Pappachan; Azfer, Asim

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006331649

PCT Pub. Number WO2007/075845

Priority 60/826,428 21.09.06 US; 60/751,927 20.12.05 US

Filing date 20 December 2006

Wipo publication date 5 July 2007

Acceptance publication date 27 September 2012

International Classifications

A61K 38/55 Medicinal preparations containing peptides - Protease inhibitors

A61K 48/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07H 21/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12P 21/06 Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Event Publications

14 August 2008 PCT application entered the National Phase

  PCT publication WO2007/075845 Priority application(s): WO2007/075845

27 September 2012 Application Accepted

  Published as AU-B-2006331649

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006331653-Treatment methods using triaryl methane compounds

2006331645-Omega 3 fatty acid formulations